Table TDI-10 part (viii). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using volatile inhalants as primary drug

Country

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known

Age not known

Total

Czech Republic

4

23

6

1

0

0

0

0

34

0

34

Germany

6

6

0

0

0

0

0

0

12

0

12

Greece

1

2

0

0

0

0

0

0

3

0

3

Cyprus

0

0

1

0

0

0

0

0

1

0

1

Latvia

4

5

0

0

0

0

0

0

9

0

9

Hungary

12

38

8

7

2

3

1

0

71

0

71

Netherlands

0

0

0

0

0

1

0

1

2

0

2

Slovenia

0

0

1

0

0

0

0

0

1

0

1

Slovakia

2

15

2

0

0

0

0

0

19

0

19

Finland

0

1

0

0

0

0

0

0

1

0

1

Sweden

3

2

0

1

1

0

0

0

7

0

7

United Kingdom

80

60

11

11

13

2

6

1

184

0

184

Bulgaria

0

2

0

0

0

0

0

0

2

0

2

Romania

0

6

3

1

1

0

0

0

11

0

11

Total

112

160

32

21

17

6

7

2

357

0

357

Source:

2004 Reitox national reports - TDI outpatient treatment centres – see [Table TDI-14]

Data filter | tditab10h-en.xml